NCT05627674View on ClinicalTrials.gov

Precision Prevention Strategy to Increase Uptake and Engagement in Lung Cancer Screening and Smoking Cessation Treatment

NAEnrolling by invitationINTERVENTIONAL
Enrollment

915

Participants

Timeline

Start Date

January 1, 2023

Primary Completion Date

August 31, 2027

Study Completion Date

August 31, 2028

Conditions
SmokingSmoking CessationTobacco Use Cessation
Interventions
BEHAVIORAL

Usual Care

Usual care incorporates guideline awareness and brief advice.

BEHAVIORAL

RiskProfile-Clin

RiskProfile-Clin incorporates standard brief advice and guideline awareness plus specific patient risk feedback using clinical factors.

BEHAVIORAL

RiskProfile-Gen

RiskProfile-Gen incorporates standard brief advice and guideline awareness plus specific patient risk feedback using clinical factors and genetic factors.

Trial Locations (1)

63110

Washington University School of Medicine, St Louis

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Washington University School of Medicine

OTHER

NCT05627674 - Precision Prevention Strategy to Increase Uptake and Engagement in Lung Cancer Screening and Smoking Cessation Treatment | Biotech Hunter | Biotech Hunter